Novozymes A/S – (NASDAQ:NVZMY) issued its quarterly earnings data on Friday. The biotechnology company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.39 by $0.03, Morningstar.com reports. The firm had revenue of $522.72 million for the quarter.

Shares of Novozymes A/S – (NVZMY) traded up 1.68% during trading on Friday, hitting $45.50. 11,411 shares of the stock were exchanged. Novozymes A/S – has a 12-month low of $31.57 and a 12-month high of $46.93. The firm has a 50 day moving average of $44.86 and a 200-day moving average of $42.18. The company has a market cap of $13.51 billion and a price-to-earnings ratio of 28.07.

ILLEGAL ACTIVITY WARNING: “Novozymes A/S – (NASDAQ:NVZMY) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS” was first posted by Daily Political and is the property of of Daily Political. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/08/12/novozymes-as-nasdaqnvzmy-releases-quarterly-earnings-results-misses-expectations-by-0-03-eps.html.

Several analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Novozymes A/S – from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective for the company in a research report on Thursday. Jefferies Group LLC restated a “hold” rating and set a $47.50 price objective on shares of Novozymes A/S – in a research report on Tuesday, May 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. Novozymes A/S – presently has a consensus rating of “Hold” and an average target price of $49.75.

About Novozymes A/S –

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America.

Receive News & Ratings for Novozymes A/S - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S - and related companies with MarketBeat.com's FREE daily email newsletter.